“Structure-Based Design and Computational Validation of Novel 1,3,4-Thiadiazole-Peptide Conjugates as Selective Cyclin-Dependent Kinase-2 (CDK2) Inhibitors for Lung Cancer Therapy”, Pjmcr, vol. 5, no. 2, pp. 1174–1180, Apr. 2026, doi: 10.66021/pakmcr903.